GSK diabetes drug set for European approval

[riky]

GSK diabetes drug set for European approval

<p><a href="http://news.yahoo.com/gsk-39-diabetes-drug-set-european-approval-110655102--sector.html"><img src="http://l.yimg.com/bt/api/res/1.2/d8EiKU10JeUDPTP_9A1HMA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-01-24T110655Z_1_CBREA0N0UVU00_RTROPTP_2_BRITAIN.JPG" width="130" height="86" alt="Signage is pictured on the company headquarters of GlaxoSmithKline in west London" align="left" title="Signage is pictured on the company headquarters of GlaxoSmithKline in west London" border="0" /></a>GlaxoSmithKline said on Friday European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan. Albiglutide belongs to the same class of injectable GLP-1 drugs as Victoza from Novo Nordisk, as well as Byetta and Bydureon from Bristol-Myers Squibb and AstraZeneca. A positive recommendation for a drug by the European Medicines Agency (EMA) is generally followed by a marketing authorization by the European Commission. GlaxoSmithKline (GSK) said a final decision was anticipated later this quarter.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login